Skip to main content
Nephrology Dialysis Transplantation logoLink to Nephrology Dialysis Transplantation
. 2011 Nov 25;27(6):2533–2546. doi: 10.1093/ndt/gfr619

The authority of next-of-kin in explicit and presumed consent systems for deceased organ donation: an analysis of 54 nations

Amanda M Rosenblum 1, Lucy D Horvat 1,2, Laura A Siminoff 3, Versha Prakash 4, Janice Beitel 4, Amit X Garg 1,2,
PMCID: PMC3363979  PMID: 22121233

Abstract

Background.

The degree of involvement by the next-of-kin in deceased organ procurement worldwide is unclear. We investigated the next-of-kin’s authority in the procurement process in nations with either explicit or presumed consent.

Methods.

We collected data from 54 nations, 25 with presumed consent and 29 with explicit consent. We characterized the authority of the next-of-kin in the decision to donate deceased organs. Specifically, we examined whether the next-of-kin’s consent to procure organs was always required and whether the next-of-kin were able to veto procurement when the deceased had expressed a wish to donate.

Results.

The next-of-kin are involved in the organ procurement process in most nations regardless of the consent principle and whether the wishes of the deceased to be a donor were expressed or unknown. Nineteen of the 25 nations with presumed consent provide a method for individuals to express a wish to be a donor. However, health professionals in only four of these nations responded that they do not override a deceased’s expressed wish because of a family’s objection. Similarly, health professionals in only four of the 29 nations with explicit consent proceed with a deceased’s pre-existing wish to be a donor and do not require next-of-kin’s consent, but caveats still remain for when this is done.

Conclusions.

The next-of-kin have a considerable influence on the organ procurement process in both presumed and explicit consent nations.

Keywords: consent, deceased donor, health policy, law, next-of-kin

Introduction

There is a global organ shortage while the number of individuals on waiting lists continues to grow [14]. In 2010, 4529 Canadians were on the waiting list and 247 died waiting [5]. Similarly, there are currently 7686 individuals in the UK on the waiting list and 111 105 such individuals in the USA [6, 7]. To address this organ shortage, policy makers in various nations have debated the merits of legislative changes to consent policies for organ donation after death [810]. One strategy that has been vigorously debated in several nations is the implementation of ‘presumed consent’ for deceased organ donation. Presumed consent, sometimes referred to as the ‘opt-out’ approach, is a legislative organ donation policy that assumes an individual has a desire to donate unless he or she makes a statement of objection to donation. In contrast, explicit consent policies such as ‘first person consent’ require an individual to ‘opt-in’ by proactively affirming a desire to be a donor such as signing a donor card or indicating donor status on a driver’s license. Otherwise the next-of-kin is consulted to determine the deceased’s preferences with respect to deceased organ donation.

Nations with presumed consent have higher rates of deceased organ donation when contrasted to nations with explicit consent [1113]. However, some authors remain unconvinced that presumed consent legislation alone explains this variation [14, 15]. There has also been resistance by the North American public to the idea of switching to an opt-out system [16, 17]. Interestingly, there is considerable range in the proportion of family members who refuse donation in both explicit and presumed consent nations, and both consent systems have an average family refusal rate of 34–38% [18]. However, data on family refusals are very limited, and values are not available for all nations. Due to the nature of deceased donation, the next-of-kin are often relied on by transplant officials in the organ procurement process. We set out to determine whether there are similarities across the two consent systems in how the next-of-kin are involved in the decision to donate after death. Specifically, we examined whether in practice nations always require the next-of-kin’s consent to procure organs, and whether the next-of-kin were able to veto procurement when the deceased had expressed a wish to donate. We collected data from 54 nations to compare and contrast the authority of next-of-kin in explicit and presumed consent systems for deceased organ donation.

Materials and methods

Definitions of presumed and explicit consent

We used World Health Organization definitions of presumed and explicit consent [19]. Explicit consent is defined as a system in which ‘cells, tissues or organs may be removed from a deceased person if the person had expressly consented to such removal during his or her lifetime’. Presumed consent is defined as a system that ‘permits material to be removed from the body of a deceased person for transplantation and, in some countries, for anatomical study or research, unless the person had expressed his or her opposition before death by filing an objection with an identified office or an informed party reports that the deceased definitely voiced an objection to donation’. Some nations have also proposed a ‘soft’ presumed consent law, where the next-of-kin is still involved in the donation decision [20].

Eligible nations

Our data of interest, next-of-kin involvement in deceased organ donation in nations with presumed and explicit consent, are presented in Figure 1. We first considered all nations where deceased organ donation is practiced as identified by the World Health Organization. We collected relevant transplant legislation and/or guidelines from each nation and categorized each nation as either presumed or explicit consent [19]. Foreign language legislation was translated into English. An example of a deceased donation clause that was interpreted as presumed consent was ‘if a deceased person did not express objection, when alive, it is allowed to recover cells, tissues or organs from such person human cadaver for transplantation purposes [21]’. An example of an explicit consent clause was ‘any person who has attained the age of 16 years may consent, (i) in writing signed by the person at any time or (ii) orally in the presence of a least two witnesses during the person’s last illness that the person’s body or the part or parts thereof specified in the consent be used after the person’s death for therapeutic purposes, medical education or scientific research [22]’. For nations with state level legislation, attempts were made to obtain each state’s legislation to determine if there was a difference in consent policies between states.

Fig. 1.

Fig. 1.

Flow diagram of data collected for each eligible nation.

Data collection

Data collection occurred from May 2009 to August 2010. Data were independently abstracted by a single author (A.M.R.) from government websites, legal databases and kidney, nephrology and transplantation foundations’ websites. Data were then independently reviewed by a second author (L.D.H.) for accuracy. Our categorization of each nation as presumed or explicit consent was verified with a second source, such as a published scientific article (Supplementary Appendix 1). In most cases, we also collected information directly from health professionals via electronic mail to ensure proper classification of the nation’s consent principle, confirm the appropriate legislation was collected and gain insight into the daily practices of deceased organ procurement (Supplementary Appendix 2). We gathered information to characterize the authority of the next-of-kin in the donation decision, specifically whether nations always required the next-of-kin’s consent and whether a validly recorded wish to be a donor was fulfilled. Electronic mail was utilized because of its ability to provide a clear paper trail and help reduce language misinterpretations. Telephone calls were utilized when requested, after which a follow-up email summarizing the call was sent back to the health professional for member checking. Health professionals included members of national kidney, nephrology and transplant foundations, ministry of health personnel and transplant staff. We sent all findings back to health professionals via electronic mail for review to ensure data quality and accuracy.

Results

We obtained data from 49 (75%) of the 65 nations reported to have active deceased organ donation programs by the World Health Organization (Supplementary Appendix 3) [M. Carmona (personal communication)]. An additional five nations (Armenia, Belarus, Costa Rica, Ecuador and Malta) were found through contact with nation representatives to also have deceased organ donation, so the total number of countries included in this review was 54 (Table 1, Figure 2). For the 16 missing nations, data collection was incomplete either because the required information was not available and/or because the health professional was non-responsive.

Table 1.

Legislation by nationa

Nation Province/Territory/State/Region Name of legislation Consent Source Source type
Armenia Law on Organ and Tissue Transplantation, 2002 Presumedb National Assembly of the Republic of Armenia [23] (Hovhannisyan, L. Yerevan. June 2010) Website and personal communication
Australia Australian Capital Territory Transplantation and Anatomy Act 1978 Explicit The ACT Legislation Register [24] Website
New South Wales Human Tissue Act 1983 New South Wales Government [25] Website
Northern Territory Human Tissue Transplant Act 1979 Northern Territory Government—Department of the Chief Minister [26] Website
Queensland Transplantation and Anatomy Act 1979 Queensland Government—Office of the Queensland Parliamentary Counsel [27] Website
South Australia Transplantation and Anatomy Act 1983 Government of South Australia—Attorney-General’s Department [28] Website
Tasmania Human Tissue Act 1985 Tasmania’s Consolidated Legislation Online [29] Website
Victoria Human Tissue Act 1982 Victoria Government Health Information [30] Website
Western Australia Human Tissue and Transplantation Act 1982 Government of Western Australia—State Law Publisher [31] Website
Austria Hospitals Law of 18 December 1956, Paragraph 62a-e, 1982 Presumed Gesundheit Österreich GmbH [32] Website
Belarus Law of the Republic of Belarus ‘On Transplantation of Human Organs and Tissues’ Presumed The Belarusian Medical Academy of Postgraduate Education (Komisarov, K. Minsk. June 2010) Personal communication
Belgium Law of 13 June 1986 Presumedc Moniteur Belge [33] Website
Brazil Law No. 9.434 of 4 February 1997 Explicit Ministério da Saúde [3436] Website
Law No. 10.211 of 23 March 2001
Decree No. 2.268 of 30 June 1997
Canada Alberta Human Tissue and Organ Donation Act, 2006 Explicit CanLII Database [22, 3748] Website
British Columbia Human Tissue Gift Act 1996
Manitoba Human Tissue Gift Act, 1987
New Brunswick Human Tissue Gift Act, 2004
Newfoundland and Labrador Human Tissue Act, 1990
Northwest Territories Human Tissue Act, 1988
Nova Scotia Human Tissue Gift Act, 1989
Nunavut Human Tissue Act, 1988
Ontario Trillium Gift of Life Network Act, 1990
Prince Edward Island Human Tissue Donation Act, 1988
Quebec Civil Code of Quebec
Saskatchewan Human Tissue Gift Act, 1978
Yukon Human Tissue Gift Act, 2002
Chile Law No. 20.413 of January 6, 2010 Presumedd Biblioteca del Congreso Nacional de Chile [49] Website
Colombia Law No. 9, 1979 Presumed Punta Cana Group [50] Website
Law No. 73, 1988
Law No. 919, 2004
Decree 2493, 2004
Resolution 2640, 2005
Costa Rica Law No. 7409 of 27 October 1994 Presumed Punta Cana Group [50] Website
Croatia Law RH 50/88 Presumed Donor Network of Croatia [51] Website
Law RH 177/2004
Rule No. 152/2005
Cuba Law No. 41 of 13 July 1983 on public health Explicit Legislative Responses to Organ Transplantation [52] Book
Decree No. 139 of 4 February 1988 Trasplante [53] Website
Czech Republic Act 285/2002 Coll. Of 30 May 2002 on donation, removal, and transplantation of organs and tissues Presumed Transplants Coordinating Center (KST) (Fryda, P. Prague. March 2010) Personal communication
Denmark Sundhedsloven – LBK No. 95 of 7 February 2008 Explicit Retsinformation [54] Website
Ecuador Law No. 58 of 27 July 1994 Presumed Instituto Ecuatoriano de Dialisis y Trasplantes (Ortiz-Herbener, F. Guayaquil. July 2009) Personal communication
Estonia Rakkude, Kudede Ja Elundite Käitlemise Ja Siirdamise Seadus Explicit Electronic Riigi Teataja (ERT) [55] Website
Finland No. 101/2001 Act on the medical use of human organs and tissues Presumed Finlex [56, 57] Website
Law No. 547 of 11 May 2007 amending Law No. 101
France Public Health Code Presumed Legifrance [58] Website
The Transplantation Act, 5 November 1997 Explicit Deutsche Stiftung Organ transplantation (Norba, D. June 2009. Frankfurt) Bundesgesetzblatt online [59] Personal communication
Germany Amendments to the Transplantation Act, 2007 Website
Iceland Act No. 16 of 6 March 1991 Explicit Althingi [60] Website
India Act No. 42 of 1994, Transplantation of Human Organs Act Explicit CommonLII [61] MOHAN Foundation [62] Website
Transplantation of Human Organs (Amendment) Rules 2008 Website
Ireland n/a Explicit n/a n/a
Israel Organ Transplant Act, 2008 Explicit Israel Ministry of Health (Ashkenazi, T. Tel Aviv. May 2010) Personal communication
Italy Law No. 91 of 1 April, 1999 Ministerial Decree of 8 April 2000 Presumed Portale Della Normativa Sanitaria [63, 64] Website
Japan Law No. 104 of 16 July 1997e Explicit WHO International Digest of Health Legislation [65] Website
Kuwait Decree-Law No. 55 of 20 December 1987 Explicit Legislative Responses to Organ Transplantation [52] Book
Lithuania Law on Donation and Transplantation of Human Tissues, Cells and Organs Explicit Lithuanian National Transplantation Bureau (NTB) [66] Website
Luxembourg Law of 25 November 1982 Presumed Luxembourg-Transplant [67] Website
Malaysia Human Tissues Act 1974 Explicit The Attorney General of Malaysia [68] Website
Malta n/a Explicit Transplant Support Group (Debattista, A. Hamrun. June 2010) Personal communication
Mexico Ley General de Salud Explicit Centro Nacional de Trasplantes [69] Website
Reglamento de la Ley General de Salud
Lineamientos para la asignación y distribución de órganos y tejidos
Netherlands The Organ Donation Act, 1996 Explicit Overheid [70] Website
New Zealand Human Tissue Act 2008 Explicit The Parliamentary Counsel Office (PCO) [71] Website
Norway Law No. 6 of 9 February 1973 Presumed Lovdata [72] Website
Paraguay Law No. 1246/98 Presumed Punta Cana Group [50] Website
Philippines Republic Act No. 7170 Explicit Chan Robles Virtual Law Library [73] Website
Poland The Cell, Tissue and Organ Recovery, Storage and Transplantation Act, 2005 Presumed Poltransplant [21] Website
Romania Law No. 95/2006 Explicit Agenţtia Nationalã de Transplant [74] Website
Russia Law of 22 December 1992 Presumed Central Clinical Hospital of Russian Academy of Sciences (Pishchita, A. Moscow. June 2010) Personal communication
Saudi Arabia Procedure of Deceased Organ Donation Explicit Saudi Center for Organ Transplantation [75] Website
Singapore Human Organ Transplant Act Presumed Singapore Statutes Online [76, 77] Website
The Medical (Therapy, Education and Research) Act
Slovak Republic Law 576/2004, of 21 October 2004 Presumed Slovenské Centrum Orgánových Transplantácií [78] Website
Slovenia The Removal and Transplantation of Human Body Parts for the Purposes of Medical Treatment Act Presumed Uradni list RS [79] Website
South Africa National Health Act, 2003 Explicit Department of Health [80] Website
South Korea Law 8852 Explicit Ulsan University Medical College (Kim, J. H. Seoul, June 2010) Personal communication
Spain Law No. 30 of 27 October 1979 RD 2070/1999 on the removal and transplantation of organs Presumed Global Observatory on Donation and Transplantation [81] Website
Sweden Law No. 831 of 1 June 1995 Presumed Riksdag [82] Website
Switzerland Federal Act of 8 October 2004 on the Transplantation of Organs, Tissues and Cells (Transplantation Act)f Explicit The Federal Authorities of the Swiss Confederation [83] Website
Thailand Rules of the Medical Council on the Observance on Medical Ethics Explicit Chulalongkorn University (Nivatvongs, S. Bangkok. June 2010) Personal communication
Medical Council's Announcement on Criteria for Brain Death Diagnosis
Tunisia Law No. 91-22 of 25 March 1991 Presumed CHU la Rabta (Hamouda, C. Tunis. June 2010) Personal communication
Law No. 49 of 12 June 1995
Law No. 18 of 1 March 1999
Decree No. 97 of 13 June 1997
Ordinance of 28 July 2004
Turkey Law #2238 of 29 May 1979 Presumed Turkish Transplantation Society [84] Website
Law #2594 of 21 January 1982
UK Human Tissue Act 2004g Explicit Office of Public Sector Information [85, 86] Website
Human Tissue (Scotland) Act 2006
USA Uniform Anatomical Gift Acth Explicit National Conference of Commissioners on Uniform State Laws [87] Website
Venezuela Law of 3 December 1992 Explicit Punta Cana Group [50] Website
a

n/a = not applicable.

b

Switched to ‘soft’ presumed consent March 2009.

c

Removed a clause that allowed next-of-kin to object to donation in the absence of a registered wish to donate February 2007. In practice next-of-kin’s objection still respected in absence of a registered decision.

d

Changed from explicit consent to presumed consent January 2010.

e

In July 2009 revisions were adopted that will be in effect in 1 year [R. Ida (personal communication)].

f

A federal law was in enacted July 2007 abolishing the previous mixture of presumed and explicit consent canons (states).

g

Applies to England, Wales and Northern Ireland.

h

The most recent version of the UAGA has been implemented in the various states. A list can be found at http://www.anatomicalgiftact.org.

Fig. 2.

Fig. 2.

54 nations studied. Explicit consent nations in black, presumed consent countries in gray.

Legislation

Of the 54 nations, 25 have presumed consent and 29 have explicit consent. As detailed in Table 1 the consent principle has been changed or modified in five nations in recent years (Armenia, Belgium, Chile, Japan and Switzerland). We focused on their most current practice for this report. Two countries (Ireland and Malta) do not have official legislation regarding deceased organ donation, but both were operating under explicit consent when the study was conducted.

Role of next-of-kin in decision making

Nations with presumed consent

In all 25 nations with presumed consent, next-of-kin are informed of the intention to recover organs (Table 2). Variations exist in Austria and Russia, where it is necessary for the next-of-kin to be physically present in the hospital at the time of procurement to object to donation. All presumed consent nations provide a method for individuals to opt-out of donation. In addition, 19 of the 25 nations with presumed consent also provide a mechanism for individuals to register their wishes to be a donor, such as affirmative registration in an electronic registry. We found that 21 of the 25 presumed consent nations allow the next-of-kin to object and prevent a potential donation. In the other four nations (Belgium, France, Poland and Sweden) health professionals do not override the deceased’s registered wish to be a donor in the case of an objection from next-of-kin but will respect an objection if there is no such record. Exceptions and caveats to these practices are presented in Table 2.

Table 2.

Role of next-of-kin in presumed consent nations

Nation Next-of-kin informed Next-of-kin’s authorization required if wishes are unknowna Next-of-kin can veto donation
Armenia Yes n/a Yes
Austria Yesb n/a Yesb
Belarus Yes n/a Yesc
Belgium Yes Nod Noe
Chile Yes n/a Yesf
Colombia Yes Yesg Yes
Costa Rica Yes Yesg Yes
Croatia Yes Yes Yes
Czech Republic Yes n/a Yes
Ecuador Yes Yes Yes
Finland Yes Yes Noe
France Yes Noh Yes
Italy Yes Yes Yes
Luxembourg Yes Yes Yes
Norway Yes Yes Yes
Paraguay Yes Yes Yes
Poland Yes Noh Yes
Russia Yesb Yesb Yesb
Singapore Yes Yes Noe
Slovak Republic Yes n/a Yes
Slovenia Yes Yes Yesi
Spain Yes Yes Yes
Sweden Yes Noj Noe
Tunisia Yes Yes Yes
Turkey Yes Yes Yes
a

‘Wishes Unknown’ refers to nations that provide a method for individuals to express a desire to be a donor in addition to a method to objecting to deceased donation. Nations that do not provide such a means are marked not applicable (n/a).

b

Next-of-kin must be present in the hospital at the time of donation for their opinion to be considered.

c

The transplant co-ordinator has the discretion to choose if the next-of-kin’s permission is necessary. In addition, there is an authorized law agent in attendance during procurement.

d

The next-of-kin are informed of the intended procurement but permission is not explicitly asked. An objection will be respected.

e

If the deceased expressed their wish to donate, then only they can revoke the decision and upon death their decision will be respected and next-of-kin will not be able to revoke it.

f

Legally, the next-of-kin’s permission is not required if no objection is made, but if there are doubts, the next-of-kin are consulted.

g

Presumed consent is only practiced if the next-of-kin are unreachable or unknown.

h

When the deceased’s wishes are unknown, the next-of-kin is asked what the deceased’s opinion on organ donation was. However, if the next-of-kin objects to donation the removal will not occur.

i

In rare cases where the next-of-kin raises an objection against donation the physician can decide not to proceed with removal, if he/she feels continuing would have a major negative impact on the next-of-kin.

j

If next-of-kin do not object, procurement will proceed under the presumption of consent. However, next-of-kin have a legal right to object and must be informed of this right. If they cannot be reached, donation may not occur.

Nations with explicit consent

In all 29 nations with explicit consent, the next-of-kin are approached regardless of whether the wishes of the deceased are known or not. In all 29 nations, authorization from the next-of-kin is required for organ procurement if the deceased’s wishes are unknown (Table 3). In cases where the deceased validly registered their wish to become a donor, procurement will occur in four nations without requiring next-of-kin’s authorization (the Netherlands, Romania, UK and most of the USA). However, there are exceptions and changes occurring in all four nations, presented in Table 3.

Table 3.

Role of next-of-kin in explicit consent nationsa

Nation Next-of-kin’s authorization is required if deceased’s wishes are unknown Next-of-kin’s consent is required even if deceased’s wishes are documented
Australia Yes Yes
Brazil Yes Yes
Canada Yes Yes
Cuba Yes Yes
Denmark Yes Yes
Estonia Yes Yes
Germany Yes Yes
Iceland Yes Yes
India Yes Yes
Ireland Yes Yes
Israel Yes Yes
Japan Yes Yes
Kuwait Yes Yes
Lithuania Yes Yes
Malaysia Yes Yes
Malta Yes Yes
Mexico Yes Yes
Netherlands Yes Nob
New Zealand Yes Yes
Philippines Yes Yes
Romania Yes Noc
Saudi Arabia Yes Yes
South Africa Yes Yes
South Korea Yes Yes
Switzerland Yes Yes
Thailand Yes Yes
UK Yes Nob
USA Yes Nod
Venezuela Yes Yes
a

In accordance with the lack of assumption of consent in explicit consent, all nations with explicit consent systems in this study approached the next-of-kin about organ donation (whether the deceased’s wishes to be a donor were known or unknown).

b

A strong objection by the next-of-kin donation will stop procurement to avoid causing a major negative impact on the next-of-kin.

c

Permission is not formally asked or required, an objection will be respected.

d

States with first person consent make the deceased’s registered wishes paramount and procurement can occur with consent from the next-of-kin. However next-of-kin are required for a medical and social history of the potential donor before procurement can occur [M. Devenny (personal communication)].

Discussion

Several nations have debated the merits of changing the consent principle of deceased donation legislation from explicit to presumed consent [8891]. Presumed consent nations have been shown to have statistically higher rates of deceased donation than explicit consent nations [1113]. However, even supporters of presumed consent legislation concede that it is one of the more controversial strategies to improving donation rates in explicit consent nations, and it could divert attention and efforts from other proven strategies [92]. Indeed, studies conducted on both the Canadian and American public demonstrate a resistance to switching to this type of consent system [16, 17]. The importance of public support for such a legislative change was exemplified by Brazil’s unsuccessful implementation of presumed consent, which resulted in the policy being reverted back to explicit consent [93]. There has also been a recent call for research on personal-level factors that may affect deceased donation rates, particularly the role of next-of-kin [94].

To address this need, we conducted a global review to better understand the authority next-of-kin have in the decision to pursue deceased organ donation in nations with presumed and explicit consent. The results of this study help inform the current debate as to whether nations with explicit consent should consider a switch to presumed consent legislation to improve their deceased organ donation programs. Organ procurement systems are complex with key differences between what is legislated and what is done in practice. We found that many nations with presumed consent legislation follow a much softer system of consent in reality, which almost always includes next-of-kin in the decision making. The next-of-kin have a considerable influence over the decision to procure organs in both presumed and explicit consent nations. For example, while it was expected that next-of-kin approval would be required for procurement in all explicit consent nations, we were surprised to learn the same is true in many nations with presumed consent and that most countries permit next-of-kin to object to donation. Furthermore, of the 19 presumed consent nations that provide a method for individuals to express a wish to be a donor, 15 nations still require the next-of-kin’s authorization for organ procurement even when the deceased has registered a wish to become a donor. Deceased donation rates without context can also be misleading. For example, according to the Global Observatory on Donation and Transplantation, Spain (a presumed consent nation) has the highest deceased donation rate per million population (p.m.p.) (34.13 p.m.p.) [95]. However, the founder and director of the Organizacion Nacional de Trasplantes (Spain’s governing transplantation organization) has repeatedly noted that Spain’s high levels of deceased donation should be attributed to its ‘Spanish Model’ rather than its legislation [14, 96, 97]. In Spain, transplant co-ordinators are required by law to search for a refusal by the deceased but since there is no national non-donor registry and most individuals do not record their decision (e.g. by carrying a donor card), the next-of-kin are consulted as a proxy decision-maker [98]. In addition, a series of organizational measures including a multi-level transplant co-ordinator network are used to facilitate transplantation [99]. It remains unclear whether the Spanish Model is feasible for nations with different infrastructure and economic constraints. An interesting comparison is the USA, which has the third highest rate for deceased donation across all nations and the highest rate amongst nations with explicit consent (26.27 p.m.p.) [95]. The USA has focused on maximizing the consent rate from next-of-kin. Available data show that the proportion of families that refuse donation varies considerably in both explicit and presumed consent nations, although on average both consent systems have a family refusal rate of approximately 34–38% [18]. Unfortunately, data on family refusals are very limited, and this value should be interpreted with caution since values are not available from all nations, rendering the rate to be inconclusive. Even so, previous work and our review both suggest that improvement of factors such as next-of-kin consent may have a larger and more immediate effect on transplantation rates than legislative changes [15]. Our results suggest that the next-of-kin strongly influence the decision to pursue organ donation in both consent systems. Future studies investigating the relationship between family refusals and donation rates are warranted.

Some donation programs have recognized this area of opportunity and are trying to improve next-of-kin authorization through the transplant co-ordinator. Training programs, such as the European Donor Hospital Education Programme (EDHEP) and the Donor Action Program, are designed to help improve the transplant staff’s communication about death and donation to the next-of-kin [92,100102]. There has also been a focus on the dialogue between the co-ordinator and the next-of-kin. The ‘presumptive approach’ utilizes assumptive language, for example saying ‘when you decide to donate’ instead of ‘if you decide to donate’ [103]. The style has been criticized as undermining free and informed consent [104]. A less assumptive approach is used by some transplant co-ordinators in presumed consent European nations, wherein they ask the next-of-kin what the deceased would have wanted instead of explicitly asking for consent. Proponents of this method argue that the burden of the decision is placed back on the deceased instead of the next-of-kin [92]. Encouragingly, this style is not limited to presumed consent nations and is meant to be part of ‘first person consent’ [105]. Future studies on the exact phrasing transplant co-ordinators employ when approaching the next-of-kin about donation and variations in practice worldwide are warranted.

The limitations of our study are that we were unable to describe practices in 16 (25%) nations where transplantation is performed because of unreliable or unavailable data. We also dichotomized data for comparison reasons; however, it should be emphasized that these data are highly nuanced. However, our study does have a number of strengths. To our knowledge, this is the first comprehensive study to compare the authority of the next-of-kin in organ donation decision making in nations with explicit and presumed consent. We collected data from 54 nations to provide a broad overview of the issue, and we included nations from all five major regions as defined by the United Nations [106]. We only reported data collected and confirmed by health professionals to ensure accuracy.

It is important to emphasize that deceased donation programs are complex, affected not only by law, administration and infrastructure but also ideology and values. It is improbable that any single strategy or approach will cause a marked improvement on deceased donation rates. While presumed consent nations have demonstrated higher rates of deceased donation, the authority of the next-of-kin in the procurement process is a feature policy makers should factor into their decision when deciding whether to switch to presumed consent legislation. When an individual dies, best methods to support the wishes of the deceased, the wishes of the next-of-kin and the practice of transplantation remain a focus for research and quality improvement.

Supplementary data

Supplementary data are available online at http://ndt.oxfordjournals.org.

Supplementary Data

Acknowledgments

We thank health professionals from 54 nations who provided or reviewed data for accuracy. We thank Dariuz Gozdzik and Stephen Woo for their help with translation.

Funding. L.H. was supported by a Schulich Graduate Scholarship from the University of Western Ontario and a research award from the Lawson Health Research Institute. Dr A.G. was supported by a Clinician Scientist Award from the Canadian Institutes of Health Research.

Conflict of interest statement. None declared.

References

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Data

Articles from Nephrology Dialysis Transplantation are provided here courtesy of Oxford University Press

RESOURCES